1. Home
  2. KEYS vs IQV Comparison

KEYS vs IQV Comparison

Compare KEYS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Keysight Technologies Inc.

KEYS

Keysight Technologies Inc.

N/A

Current Price

$284.92

Market Cap

40.2B

Sector

Industrials

ML Signal

N/A

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

N/A

Current Price

$164.69

Market Cap

41.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KEYS
IQV
Founded
1939
1982
Country
United States
United States
Employees
N/A
93000
Industry
Industrial Machinery/Components
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.2B
41.3B
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
KEYS
IQV
Price
$284.92
$164.69
Analyst Decision
Buy
Strong Buy
Analyst Count
12
16
Target Price
$267.33
$230.56
AVG Volume (30 Days)
1.6M
2.6M
Earning Date
05-25-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
39.89
4.67
EPS
1.63
7.84
Revenue
$5,375,000,000.00
$9,739,000,000.00
Revenue This Year
$25.40
$6.76
Revenue Next Year
$7.89
$5.85
P/E Ratio
$174.61
$21.88
Revenue Growth
7.95
41.60
52 Week Low
$121.43
$134.65
52 Week High
$317.00
$247.05

Technical Indicators

Market Signals
Indicator
KEYS
IQV
Relative Strength Index (RSI) 60.65 35.39
Support Level $159.59 $156.43
Resistance Level $317.00 $166.38
Average True Range (ATR) 12.96 6.46
MACD -2.45 1.81
Stochastic Oscillator 58.61 21.20

Price Performance

Historical Comparison
KEYS
IQV

About KEYS Keysight Technologies Inc.

Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: